These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23957239)

  • 1. Adiponectin and lipoprotein metabolism.
    Christou GA; Kiortsis DN
    Obes Rev; 2013 Dec; 14(12):939-49. PubMed ID: 23957239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin is an important determinant of apoA-I catabolism.
    Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.
    Rocha MP; Maranhão RC; Seydell TM; Barcellos CR; Baracat EC; Hayashida SA; Bydlowski SP; Marcondes JA
    Fertil Steril; 2010 Apr; 93(6):1948-56. PubMed ID: 19765700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
    Michos ED; Sibley CT; Baer JT; Blaha MJ; Blumenthal RS
    J Am Coll Cardiol; 2012 Jun; 59(23):2058-64. PubMed ID: 22520249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
    Watts GF; Barrett PH
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):36-41. PubMed ID: 12125229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low adiponectin levels in primary hypertriglyceridemic male patients.
    Gómez Rosso L; Meroño T; Benítez MB; López G; Giunta G; D'Ambrosio ML; Wikinski R; Cuniberti L; Brites F
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):135-9. PubMed ID: 18472252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
    Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
    Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.
    Yanai H; Yoshida H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between adiponectin, an adiponectin gene polymorphism, and high-density lipoprotein particle size: from the Mima study.
    Tsuzaki K; Kotani K; Sano Y; Fujiwara S; Gazi IF; Elisaf M; Sakane N
    Metabolism; 2012 Jan; 61(1):17-21. PubMed ID: 21820140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Oida K; Takeda R
    Artery; 1981; 9(6):477-93. PubMed ID: 6802107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of hypertriglyceridemia].
    Imano H; Iso H
    Nihon Rinsho; 2013 Sep; 71(9):1528-35. PubMed ID: 24205710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity on high-density lipoprotein metabolism.
    Rashid S; Genest J
    Obesity (Silver Spring); 2007 Dec; 15(12):2875-88. PubMed ID: 18198293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adiponectin is associated with less atherogenic lipoprotein phenotype.
    Shin MJ; Kim OY
    Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):770-5. PubMed ID: 20554178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HDL on adipose tissue metabolism and adiponectin expression.
    Van Linthout S; Foryst-Ludwig A; Spillmann F; Peng J; Feng Y; Meloni M; Van Craeyveld E; Kintscher U; Schultheiss HP; De Geest B; Tschöpe C
    Atherosclerosis; 2010 Jun; 210(2):438-44. PubMed ID: 20202635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.